Diabetic Ulcers Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
Condition:   Diabetic Foot Ulcer Interventions:   Drug: NOX-1416+SOC;   Other: Placebo+SOC Sponsor:   NOxy Health Products, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

Nu-3 Gel for Infected Diabetic Foot Ulcers
Condition:   Diabetic Foot Infection Interventions:   Drug: 5% Nu-3 gel;   Drug: 10% Nu-3 gel;   Drug: Placebo Sponsor:   Lakewood-Amedex Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
Condition:   Diabetic Foot Ulcer Interventions:   Drug: NOX-1416+SOC;   Other: Placebo+SOC Sponsor:   NOxy Health Products, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

Nu-3 Gel for Infected Diabetic Foot Ulcers
Condition:   Diabetic Foot Infection Interventions:   Drug: 5% Nu-3 gel;   Drug: 10% Nu-3 gel;   Drug: Placebo Sponsor:   Lakewood-Amedex Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
Condition:   Diabetic Foot Ulcer Interventions:   Drug: NOX-1416+SOC;   Other: Placebo+SOC Sponsor:   NOxy Health Products, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

Nu-3 Gel for Infected Diabetic Foot Ulcers
Condition:   Diabetic Foot Infection Interventions:   Drug: 5% Nu-3 gel;   Drug: 10% Nu-3 gel;   Drug: Placebo Sponsor:   Lakewood-Amedex Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
Condition:   Diabetic Foot Ulcer Interventions:   Drug: NOX-1416+SOC;   Other: Placebo+SOC Sponsor:   NOxy Health Products, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

Nu-3 Gel for Infected Diabetic Foot Ulcers
Condition:   Diabetic Foot Infection Interventions:   Drug: 5% Nu-3 gel;   Drug: 10% Nu-3 gel;   Drug: Placebo Sponsor:   Lakewood-Amedex Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
Condition:   Diabetic Foot Ulcer Interventions:   Drug: NOX-1416+SOC;   Other: Placebo+SOC Sponsor:   NOxy Health Products, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

Nu-3 Gel for Infected Diabetic Foot Ulcers
Condition:   Diabetic Foot Infection Interventions:   Drug: 5% Nu-3 gel;   Drug: 10% Nu-3 gel;   Drug: Placebo Sponsor:   Lakewood-Amedex Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
Condition:   Diabetic Foot Ulcer Interventions:   Drug: NOX-1416+SOC;   Other: Placebo+SOC Sponsor:   NOxy Health Products, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

Nu-3 Gel for Infected Diabetic Foot Ulcers
Condition:   Diabetic Foot Infection Interventions:   Drug: 5% Nu-3 gel;   Drug: 10% Nu-3 gel;   Drug: Placebo Sponsor:   Lakewood-Amedex Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU)
Condition:   Diabetic Foot Ulcer Interventions:   Drug: NOX-1416+SOC;   Other: Placebo+SOC Sponsor:   NOxy Health Products, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials

Study on Regeneration of Skin Defects in Diabetic Ulcers Treated With New Electrospun Material PLCL/Fg
Condition:   Diabetic Foot Interventions:   Drug: PLCL/Fg group;   Drug: control group Sponsor:   Guili Wang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials